Top Harvest Capital
VC Fund
Menlo Park, United States
Top Harvest Capital is a VC fund in Menlo Park focused on Artificial Intelligence and Biotechnology. Top Harvest Capital invests worldwide in early-stage startups leveraging machine learning / AI.
- Total investments:
- 22
- Last investment:
- Lead investor:
- 18%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Top Harvest Capital invests in
Stages Top Harvest Capital invests in
Countries Top Harvest Capital invests in
Round sizes
Round size
- Seed
- $4.3M–$29M
- Series A
- $13M–$20M
- Series B
- $30M–$60M
Investment Focus
Industry
- Artificial Intelligence 10 (45%)
- Biotechnology 6 (27%)
- Health Care 5 (23%)
- Machine Learning 5 (23%)
- Software 4 (18%)
Stage
- Seed 14 (64%)
- Series A 3 (14%)
- Series B 2 (9%)
- Funding Round 1 (5%)
- Venture - Series Unknown 1 (5%)
Country
- United States 13 (59%)
- France 3 (14%)
- Indonesia 1 (5%)
- Switzerland 1 (5%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| GenEdit was founded to transform the delivery of gene therapies and enable the next generation of non-viral, gene editing-based therapeutics. GenEdit’s proprietary technology, NanoGalaxy™ platform solves current delivery challenges by systematically screening its nanoparticle library and providing safer and efficient delivery to target tissues. Thecompany's tool makes therapeutic gene editing possible and is easier to use, faster and more accurate than previous gene-editing techniques and thus has the potential for a wide range of therapeutic applications, enabling physicians to cure incurable genetic diseases. | $60M / Series B / Feb 25, 2026 | ||
| Syntracts is doing what legal AI has promised — but not delivered. We cut through the noise with a proprietary platform that doesn’t rely on prompts or third-party APIs. We turn contracts — some of the most valuable but inaccessible assets for any enterprise — into structured data with over 95% accuracy, enabling downstream workflows likenegotiation, compliance, risk, and analytics from a single source of truth. Our system adapts to each customer’s specific contracts by delivering hundreds of custom AI agents fine-tuned with synthetic legal data, ensuring unmatched security, precision, and scalability. | $6.7M / Seed / Oct 21, 2025 | ||
| Syntracts is doing what legal AI has promised — but not delivered. We cut through the noise with a proprietary platform that doesn’t rely on prompts or third-party APIs. We turn contracts — some of the most valuable but inaccessible assets for any enterprise — into structured data with over 95% accuracy, enabling downstream workflowslikenegotiation, compliance, risk, and analytics from a single source of truth. Our system adapts to each customer’s specific contracts by delivering hundreds of custom AI agents fine-tuned with synthetic legal data, ensuring unmatched security, precision, and scalability. | $5.3M / Seed / Oct 21, 2025 | ||
| Synthetica Bio develops an enterprise-scale generative AI for biopharma. It empowers discovery, clinical, and commercial teams with actionable knowledge in real-time. Its platform fine-tunes LLMs for real-time data with the verified and secure customer data store. | $3M / Seed / Jun 12, 2025 | ||
| With the use of Hedera Dx's liquid biopsy solution, hospital labs will be able to conduct clinically useful liquid biopsies on their own. This will greatly simplify tumor profiling. It is difficult to accomplish IVD compliance, privacy infrastructure, and validation, and even if these challenges are overcome, the current software workflows areinefficient to use and lack key capabilities.Hedera Dx was established on July 1, 2021 in Epalinges, Vaud. | $17M / Series A / May 27, 2025 | ||
| Youlify offers AI solutions for medical billing, denied claims investigation, and real-time financial insights. | $4.3M / Seed / Apr 16, 2025 | ||
| Voxel51 is the leading data platform for physical AI. The company's flagship product, FiftyOne, combines open-source flexibility with enterprise-grade capabilities to help teams understand and analyze their multimodal data, annotate the right samples, close quality and coverage gaps, and build models that perform reliably in the real world.Trusted by millions of developers and thousands of enterprises—including Porsche, Vivint, Berkshire Grey, and Microsoft—FiftyOne is how the world's leading AI teams build the data foundation physical AI demands. Learn more at voxel51.com. | $30M / Series B / May 16, 2024 | ||
| Leash Biosciences engages in machine learning to solve medicinal chemistry. | $9.3M / Seed / Apr 05, 2024 | ||
| Leash Biosciences engages in machine learning to solve medicinal chemistry. | $9.3M / Seed / Apr 05, 2024 | ||
| Bioptimus is a developer of a universal AI foundation model that connects biology at all sizes, from molecules to cells, tissues, and entire organisms. The company's technology turns multiscale data into actionable representations, allowing clients to spark breakthrough discoveries and expedite biomedical innovation. | $35M / Seed / Feb 20, 2024 | ||
| See all 22 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Top Harvest Capital invest in?
Top Harvest Capital invests primarily in Artificial Intelligence, Biotechnology and Health Care startups, most often at Seed and Series A stage. Most of the 22 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Top Harvest Capital invest in?
Top Harvest Capital typically joins rounds of $4.3M–$29M at Seed, $13M–$20M at Series A and $30M–$60M at Series B. These are whole funding-round sizes, not Top Harvest Capital's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Top Harvest Capital took part in.
When did Top Harvest Capital last invest?
The most recent investment recorded for Top Harvest Capital closed in Feb 2026. Shizune tracks 22 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
